Cardea
Dr. Grint has served on the Boards of Illumina, AmpliPhi Biosciences, and as the CEO of several companies. Dr. Grint’s ability to see the early potential in technology served Illumina well when Next Generation Sequencing was in its infancy as it will Cardea with its Biology-gated Transistors.
This person is not in the org chart
This person is not in any offices
Cardea
Cardea is developing a Tech+Bio Infrastructure based on proprietary Biology-gated Transistors, or Cardean Transistors.